Interestingly, Ehop-016, a Rac1 and Rac3 inhibitor [15], significantly reduced Ser2P and Ser5P levels in both cancer cell lines, although it also slightly reduced Ser7P in HeLa cells. This evidence concerns the gene RAC3 and cancer.